Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (331-340 of 657) with videos related to

Pageof 66
Sort By:
European Urology|September 29, 2015
Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate CancerJames T Kearns, Brittany Lapin, Edward Wang, et al.
American Journal of Infection Control|June 14, 2003
Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococciRichard A Mayer, Rula C Geha, Marion S Helfand, et al.
Medical Care|May 1, 1983
The Seattle evaluation of computerized drug profiles: effect on provider activitiesT D Koepsell, K H Helfand, P H Diehr, et al.
Biochemistry|November 19, 2003
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallographyMarion S Helfand, Monica A Totir, Marianne P Carey, et al.
The Journal of Biological Chemistry|October 10, 2003
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130Marion S Helfand, Christopher R Bethel, Andrea M Hujer, et al.
Gastrointestinal Endoscopy|June 7, 2000
Colonic neoplasia in patients with nonspecific GI symptomsD A Lieberman, P L de Garmo, D E Fleischer, et al.
BJU International|November 15, 2011
Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillanceBarry B McGuire, Brian T Helfand, Shilajit Kundu, et al.
BMC Veterinary Research|January 22, 2013
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitroKevin Marley, Stuart C Helfand, Wade A Edris, et al.
BMC Medical Research Methodology|September 14, 2012
Methods for the drug effectiveness review projectMarian S McDonagh, Daniel E Jonas, Gerald Gartlehner, et al.
The Journal of Urology|October 23, 2012
Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trialBrian T Helfand, Jeanette Y Lee, Victoria Sharp, et al.
Pageof 66

Showing results (331-340 of 657) with videos related to

Sort By:
Pageof 66
European Urology|September 29, 2015
Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate CancerJames T Kearns, Brittany Lapin, Edward Wang, et al.
American Journal of Infection Control|June 14, 2003
Role of fecal incontinence in contamination of the environment with vancomycin-resistant enterococciRichard A Mayer, Rula C Geha, Marion S Helfand, et al.
Medical Care|May 1, 1983
The Seattle evaluation of computerized drug profiles: effect on provider activitiesT D Koepsell, K H Helfand, P H Diehr, et al.
Biochemistry|November 19, 2003
Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallographyMarion S Helfand, Monica A Totir, Marianne P Carey, et al.
The Journal of Biological Chemistry|October 10, 2003
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130Marion S Helfand, Christopher R Bethel, Andrea M Hujer, et al.
Gastrointestinal Endoscopy|June 7, 2000
Colonic neoplasia in patients with nonspecific GI symptomsD A Lieberman, P L de Garmo, D E Fleischer, et al.
BJU International|November 15, 2011
Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillanceBarry B McGuire, Brian T Helfand, Shilajit Kundu, et al.
BMC Veterinary Research|January 22, 2013
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitroKevin Marley, Stuart C Helfand, Wade A Edris, et al.
BMC Medical Research Methodology|September 14, 2012
Methods for the drug effectiveness review projectMarian S McDonagh, Daniel E Jonas, Gerald Gartlehner, et al.
The Journal of Urology|October 23, 2012
Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trialBrian T Helfand, Jeanette Y Lee, Victoria Sharp, et al.
Pageof 66